Literature DB >> 24401674

Reninoma: the importance of renal vein renin ratios for lateralisation and diagnosis.

Martin Wolley1, Richard D Gordon, Michael Stowasser.   

Abstract

BACKGROUND/AIM: Reninomas are rare juxtaglomerular tumours which can cause severe hypertension and hypokalaemia. Diagnosis can be problematic and these tumours can be difficult to locate on imaging. In this report we aim to demonstrate the value of carefully performed renal vein renin ratios (RVRRs) to assist in locating these tumours. METHOD/
RESULTS: We report on 3 patients diagnosed with reninoma in our unit. The patients were all female, young (17, 16 and 30 years), severely hypertensive and hypokalaemic (2.5, 2.5 and 3.1 mmol/l). Plasma renin activity (PRA) was elevated (31.9, 274 and 175 ng/ml/h), and aldosterone was high-normal (19.9 ng/dl) or elevated (207 and 109.3 ng/dl). Renal artery stenosis was excluded by renal artery Doppler, DTPA scan and angiography. Renal CT detected the lesion in 2 patients, with one lesion visible on pre- and post-contrast CT and the other on post-contrast CT only. RVRRs were performed several weeks after withdrawing interfering medications, maintaining a <40 mmol/day low-sodium diet and maintaining recumbency overnight the night before and during the procedure. Ratios before and after captopril or enalaprilat administration were obtained and lateralised the tumours in all 3 cases (dominant/non-dominant ratios of 2.3, 4.3 and 3.8). All of the patients underwent nephrectomy yielding a typical juxtaglomerular tumour and resulting in cure of hypertension and hypokalaemia.
CONCLUSIONS: Reninoma should be suspected in young hypertensives (especially females) with significant hypokalaemia and high PRA or direct renin concentration after renovascular hypertension has been excluded. CT imaging and carefully performed RVRRs provide the highest likelihood of locating these tumours.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24401674     DOI: 10.1159/000357410

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  8 in total

Review 1.  Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.

Authors:  Agata Buonacera; Benedetta Stancanelli; Lorenzo Malatino
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-12

2.  Reninoma presenting in pregnancy.

Authors:  Talia Diker-Cohen; Smita Baid Abraham; Mitra Rauschecker; Georgios Z Papadakis; Kashif M Munir; Eric Brown; Charalampos Lyssikatos; Elena Belyavskaya; Maria Merino; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2014-05-21       Impact factor: 5.958

3.  Elevated Renin and Aldosterone Levels in a Young Woman With Hypertension.

Authors:  Bader Kfoury; Jordana B Cohen
Journal:  Am J Kidney Dis       Date:  2020-06       Impact factor: 8.860

Review 4.  Juxtaglomerular Cell Tumor: Reviewing a Cryptic Cause of Surgically Correctable Hypertension.

Authors:  Rafid Inam; Jason Gandhi; Gunjan Joshi; Noel L Smith; Sardar Ali Khan
Journal:  Curr Urol       Date:  2019-09-10

5.  Spontaneous rupture of the kidney in the patients with synchronous renal hemangioma and nephrogenic hypertension.

Authors:  Akif Memmedoğlu; Jamal Musayev
Journal:  Turk J Urol       Date:  2015-12

6.  Spindle Cell Hemangioma and Atypically Localized Juxtaglomerular Cell Tumor in a Patient with Hereditary BRIP1 Mutation: A Case Report.

Authors:  Jan Papez; Jiri Starha; Pavel Zerhau; Denisa Pavlovska; Marta Jezova; Tomas Jurencak; Katerina Slaba; Martin Sterba; Arpad Kerekes; Tomas Merta; Terezia Haluskova; Hana Palova; Ondrej Slaby; Jaroslav Sterba; Petr Jabandziev
Journal:  Genes (Basel)       Date:  2021-02-03       Impact factor: 4.096

7.  Accurate lesion localisation facilitates nephron sparing surgery in reninoma patients: case report and discussion.

Authors:  Romy Mondschein; Edward Kwan; Claire Abou-Seif; Nieroshan Rajarubendra
Journal:  Urol Case Rep       Date:  2022-03-25

8.  Reninoma: an uncommon cause of Renin-mediated hypertension.

Authors:  Peter Trnka; Luisa Orellana; Mark Walsh; Louis Pool; Peter Borzi
Journal:  Front Pediatr       Date:  2014-08-15       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.